Group treatment for caregivers of children with brain tumors using Eye Movement Desensitization and Reprocessing
Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol Applied to Caregivers of Children With Pediatric Brain Tumor: a Feasibility Study and a Pilot Randomized Group Treatment Trial.
This study is testing if a special group therapy called EMDR can help caregivers of children who survived brain tumors feel less anxious and depressed compared to those getting regular support.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 48 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Eugenio Medea Academic / other |
| Locations | 1 site (Bosisio Parini, Lecco) |
| Trial ID | NCT06339814 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the feasibility and effectiveness of the Eye Movement Desensitization and Reprocessing (EMDR) Integrative Group Treatment Protocol for caregivers of pediatric brain tumor survivors. Caregivers often experience significant psychological distress, including anxiety and depression, comparable to trauma victims. The study will compare the EMDR treatment group, which will undergo four sessions, to a control group receiving standard treatment. The goal is to determine if EMDR can effectively reduce psychological distress in this population.
Who should consider this trial
Good fit: Ideal candidates are primary caregivers of children diagnosed with brain tumors who exhibit trauma-related symptoms.
Not a fit: Patients with severe psychiatric disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly alleviate psychological distress for caregivers of pediatric brain tumor patients.
How similar studies have performed: Previous studies have shown promise for EMDR in treating psychological distress in caregivers of adult patients, but this specific application is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * being the primary caregivers of a patient with a diagnosis of brain tumor, * evidence of one or more traumatic events causing trauma related symptoms (Impact of Event Scale-Revised \> 0, and Subjective Units of Distress \> 5); * being fluent in Italian * with at least three years of education. Exclusion Criteria: * Evidence of severe psychiatric disorders.
Where this trial is running
Bosisio Parini, Lecco
- IRCCSEMedea — Bosisio Parini, Lecco, Italy (Recruiting)
Study contacts
- Principal investigator: Maria Chiara Oprandi — IRCCS Eugenio Medea
- Study coordinator: Maria Chiara Oprandi
- Email: chiara.oprandi@lanostrafamiglia.it
- Phone: +39 340 05 18 917
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.